PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ENTHALTEND CONTIGNASTEROL-VERBINDUNGEN

PCT No. PCT/CA93/00558 Sec. 371 Date Sep. 5, 1995 Sec. 102(e) Date Sep. 5, 1995 PCT Filed Dec. 21, 1993 PCT Pub. No. WO94/14451 PCT Pub. Date Jul. 7, 1994Steroid compounds of the contignasterol family, including stereoisomers and pharmaceutically acceptable salts, as well as compositions containing...

Full description

Saved in:
Bibliographic Details
Main Authors ALLEN, THERESA M, BURGOYNE, DAVID L, ANDERSEN, RAYMOND J
Format Patent
LanguageGerman
Published 15.02.1998
Edition6
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
STEROIDS
Online AccessGet full text

Cover

More Information
Summary:PCT No. PCT/CA93/00558 Sec. 371 Date Sep. 5, 1995 Sec. 102(e) Date Sep. 5, 1995 PCT Filed Dec. 21, 1993 PCT Pub. No. WO94/14451 PCT Pub. Date Jul. 7, 1994Steroid compounds of the contignasterol family, including stereoisomers and pharmaceutically acceptable salts, as well as compositions containing these materials and a pharmaceutically acceptable carrier, are disclosed. The steroid compounds have a 3 alpha -hydroxyl, a 4 beta -hydroxyl, a 6 alpha -hydroxyl, a 7 beta -hydroxyl, a 15-ketone, a trans A/B ring juncture and a cis or trans C/D ring juncture. The compounds and compositions may be used, for example, for the prevention of inflammatory or allergic reactions, or the treatment of cardiovascular or haemodynamic disorders.
Bibliography:Application Number: AT19940902581T